Labajo, Erbien G.
HRN: 23-60-66 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2023
AMPICILLIN 500MG (VIAL)
08/26/2023
09/02/2023
IV
280mg
Q6h
AGE
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes